SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001595585-19-000259
Filing Date
2019-11-14
Accepted
2019-11-14 16:48:40
Documents
60
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q q30930201910qdocument.htm   iXBRL 10-Q 1926187
2 EXHIBIT 31.1 exhibit311ceo302certif.htm EX-31.1 11480
3 EXHIBIT 31.2 exhibit312cfo302certif.htm EX-31.2 11488
4 EXHIBIT 32.1 exhibit321ceoandcfo906.htm EX-32.1 6800
  Complete submission text file 0001595585-19-000259.txt   6978347

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20190930.xsd EX-101.SCH 42161
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcda-20190930_cal.xml EX-101.CAL 80602
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcda-20190930_def.xml EX-101.DEF 188652
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20190930_lab.xml EX-101.LAB 567963
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20190930_pre.xml EX-101.PRE 327253
29 EXTRACTED XBRL INSTANCE DOCUMENT q30930201910qdocument_htm.xml XML 1136409
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38558 | Film No.: 191221232
SIC: 2834 Pharmaceutical Preparations